Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma.
Llop S, Plana M, Tous S, Ferrando-Díez A, Brenes J, Juarez M, Vidales Z, Vilajosana E, Linares I, Arribas L, Duch M, Fulla M, Brunet A, Lozano A, Cirauqui B, Mesía R, Oliva M. Llop S, et al. Among authors: ferrando diez a. Front Oncol. 2024 Nov 25;14:1458479. doi: 10.3389/fonc.2024.1458479. eCollection 2024. Front Oncol. 2024. PMID: 39655068 Free PMC article.
Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.
Teruel I, Castellà E, Recalde S, Viñas G, Petit A, Trigueros M, Martínez-Balibrea E, Felip E, Bergamino M, Bernat-Peguera A, Cirauqui B, Quiroga V, Ferrando-Díez A, Pous A, López A, Boronat L, Soler G, Recuero J, Romeo M, Guillén P, Mesía R, Ballana E, Martínez-Cardús A, Margelí M. Teruel I, et al. Among authors: ferrando diez a. Int J Mol Sci. 2024 Nov 14;25(22):12241. doi: 10.3390/ijms252212241. Int J Mol Sci. 2024. PMID: 39596307 Free PMC article.
Deciphering HER2-low breast cancer (BC): insights from real-world data in early stage breast cancer.
Pous A, Bernat-Peguera A, López-Paradís A, Cirauqui B, Quiroga V, Teruel I, Felip E, Ferrando-Díez A, Bergamino M, Boronat L, Romeo M, Soler G, Mariño C, Rodríguez-Martínez P, Pons L, Ballana E, Martinez-Cardús A, Margelí M. Pous A, et al. Among authors: ferrando diez a. Ther Adv Med Oncol. 2024 Oct 23;16:17588359241290720. doi: 10.1177/17588359241290720. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39449733 Free PMC article.
Deciphering the impact of STAT3 activation mediated by PTPRT promoter hypermethylation as biomarker of response to paclitaxel-plus-cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Cirauqui BC, Peguera AB, Pi-Sunyer AQ, Ferrando-Díez A, Serrano JLR, Viñolas MD, García IT, García VQ, Oukadour IC, Valencia AG, Vergara PH, de Aguirre Egaña I, Herrero CQ, Carbonell OM, Paradís AL, Esteve A, Vila MM, Rosell R, Martínez-Cardús A, Mesía R. Cirauqui BC, et al. Among authors: ferrando diez a. Head Neck. 2025 Jan;47(1):57-67. doi: 10.1002/hed.27892. Epub 2024 Jul 27. Head Neck. 2025. PMID: 39072941
Assessing the reduction of viral infectivity in HPV16/18-positive women after one, two, and three doses of Gardasil-9 (RIFT): Study protocol.
López-Codony V, de Andrés-Pablo Á, Ferrando-Díez A, Fernández-Montolí ME, López-Querol M, Tous S, Ortega-Expósito C, Torrejón-Becerra JC, Pérez Y, Ferrer-Artola A, Sole-Sedeno JM, Grau C, Rupérez B, Saumoy M, Sánchez M, Peremiquel-Trillas P, Bruni L, Alemany L, Bosch FX, Pavón MA. López-Codony V, et al. Among authors: ferrando diez a. PLoS One. 2024 May 20;19(5):e0304080. doi: 10.1371/journal.pone.0304080. eCollection 2024. PLoS One. 2024. PMID: 38768231 Free PMC article.
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.
Gutiérrez-Chamorro L, Felip E, Castellà E, Quiroga V, Ezeonwumelu IJ, Angelats L, Esteve A, Perez-Roca L, Martínez-Cardús A, Fernandez PL, Ferrando-Díez A, Pous A, Bergamino M, Cirauqui B, Romeo M, Teruel I, Mesia R, Clotet B, Riveira-Muñoz E, Margelí M, Ballana E. Gutiérrez-Chamorro L, et al. Among authors: ferrando diez a. Cell Oncol (Dordr). 2024 Feb;47(1):189-208. doi: 10.1007/s13402-023-00862-1. Epub 2023 Sep 4. Cell Oncol (Dordr). 2024. PMID: 37667113 Free PMC article.
How to prevent human papillomavirus-related oropharyngeal cancer?
Ferrando-Díez A, Pavón MA, Cirauqui B, Alemany L, Mesía R. Ferrando-Díez A, et al. Curr Opin Oncol. 2023 May 1;35(3):145-150. doi: 10.1097/CCO.0000000000000937. Epub 2023 Mar 20. Curr Opin Oncol. 2023. PMID: 36966500 Review.
Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data.
Bernat-Peguera A, Trigueros M, Ferrando-Díez A, Ibáñez C, Bystrup S, Martínez-Cardús A, Margelí M, Martínez-Balibrea E. Bernat-Peguera A, et al. Among authors: ferrando diez a. Breast. 2022 Apr;62:1-9. doi: 10.1016/j.breast.2022.01.007. Epub 2022 Jan 19. Breast. 2022. PMID: 35078146 Free PMC article.